Mayne Teams up With Pliva

Pharmaceuticals and diagnostics firm Mayne Group Ltd. said that its pharmaceuticals arm, Mayne Pharma, would collaborate with international generic and specialty pharmaceutical company Pliva to develop and make two biogeneric products used by cancer patients. Mayne said it would exclusively market and distribute the products -- erythropoietin (EPO) and granulocyte colony stimulating factor (G-CSF) in Western Europe and other selected markets around the world.

The Sydney Morning Herald (http://www.smh.com.au/news/Business/Mayne-team-up-with-PLIVAs/2005/02/22/1108834770918.html?oneclick=true)